CellWell record HH-442164
Effects of high-dose vitamin D supplementation in patients with multiple sclerosis: A systematic review of efficacy and safety
Kholoud Al Ghamdi; Mohammed Alqarni; Ziyad Alamri; Mohand Al Wahhas; Muhammad Alkhaldi; Abdulrahman Alsanni; Ali Fouad Alhawaj
2026
In plain language
In a systematic review of 11 trials, high-dose vitamin D (at least 10,000 IU daily) in multiple sclerosis was safe with monitoring and reduced IL-17-related inflammation, while MRI and clinical effects were inconsistent.
- Evidence
- Established
- Design
- Systematic review
Cite this record: https://thecellwell.org/studies/HH-442164
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.